Brian Burkavage - May 11, 2022 Form 3 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Accounting Officer
Signature
/s/ Brian Burkavage
Stock symbol
IOBT
Transactions as of
May 11, 2022
Transactions value $
$0
Form type
3
Date filed
5/13/2022, 04:39 PM
Previous filing
Jun 9, 2021
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IOBT Common Stock 1.5K May 11, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IOBT Stock Option (Right to Buy) May 11, 2022 Common Stock 53K $8.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on 10/29/2022, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney